Pediatric Blood and Cancer

Aims & Scope

Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults.

Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.3
2024	2.40

SJR (SCImago Journal Rank)

Year	Value
2024	0.994

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	133

Journal Rank

Year	Value
2024	4871

Journal Citation Indicator

Year	Value
2024	3624

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

  Citation: 4072

  Authors: Jan‐Inge, AnnaCarin, Maurizio, R. Maarten, Alexandra H., Shinsaku, Stephan, Ken, David, Jacek, Gritta

• Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years

  Citation: 534

  Authors: Riccardo, Milen, Itziar, Eva, Vasanta, Rima, R. Maarten, Gritta, Dragan, Carlos, Stefaan, Johannes, Sheila, Jean

• Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis

  Citation: 492

  Authors: Carl E., Xiaoying, Claudia A., Kenneth L.

• Sirolimus for the treatment of complicated vascular anomalies in children

  Citation: 489

  Authors: Adrienne M., MarySue, Anita, Stephen, Anne, Ravi, Roshni, Richard G., Denise M.

• The pediatric preclinical testing program: Description of models and early testing results

  Citation: 419

  Authors: Peter J., Christopher L., Chandra, Debbie, Edward, Claire, Richard, E. Anders, Wendong, Richard, Hernan, Mimi, C. Patrick, John M., Joshua, Stephen T., Henry S., Charles, Joseph, Jianrong, Tiebin, Catherine A., Javed, Sherry, Jian, Malcolm A.

• The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study

  Citation: 400

  Authors: Daniel M., Vikki G., Pamela J., John A., DeoKumar, Wendy M., Joseph P., Charles A., Sue C., Melissa M., Lisa R., Marilyn, Sarah S., Leslie L.

• Standards for the Psychosocial Care of Children With Cancer and Their Families: An Introduction to the Special Issue

  Citation: 349

  Authors: Lori, Anne E., Robert B., Andrea Farkas, Mary Jo

• Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft‐tissue Sarcoma committee experience and rationale for current COG studies

  Citation: 341

  Authors: Suman, Douglas S.

• Spectrum of <i>SMARCB1/INI1</i> mutations in familial and sporadic rhabdoid tumors

  Citation: 328

  Authors: Katherine W., Laura S., Luanne M., Alexander R., Jaclyn A.

• Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)

  Citation: 326

  Authors: Michael B., Carl E., Jay, Michael, Michelle L., Ashish, Melissa, Olive, Stephan, Kim E., Carlos, Birte, Kenneth L.

---